Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05133687 |
Other study ID # |
MS-445-2021 |
Secondary ID |
|
Status |
Completed |
Phase |
Phase 3
|
First received |
|
Last updated |
|
Start date |
November 1, 2021 |
Est. completion date |
May 30, 2022 |
Study information
Verified date |
June 2022 |
Source |
Kasr El Aini Hospital |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This randomized, controlled study is designed to estimate the effects of different volumes of
plain bupivacaine 0.25% caudal block on different hemodynamic parameters assessed by
electrical cardiometry.
Description:
Introduction:
Caudal block is one of the most used regional blocks in pediatrics because it is safe and
provides efficient and adequate perioperative analgesia for most of the infra-umbilical and
lower limb procedures.[1,2] It has been proposed that the cardiovascular effects of neuraxial
blocks are less marked in children than in adults because of lower systemic vascular
resistance (SVR) in pediatric population.[3] There is a wide range of doses used in caudal
block depending on the desired dermatomal level which can range from 0.5ml/kg up to
1.25ml/kg. [1] However, studies assessing effects and safety of different volumes of caudal
blocks on different hemodynamic variables are scarce and show conflicting results due to
small sample sizes, absence of control groups, retrospective nature, different additives and
different methods for measuring the hemodynamics.[4-8] Electrical Cardiometry (EC) estimates
cardiac parameters by measuring changes in thoracic electrical bioimpedance during the
cardiac cycle using skin electrodes. It has emerged as a new noninvasive tool for assessment
of cardiac output with a good accuracy in adult and pediatric anesthesia.[9] The current
study is designed to estimate the effects of different volumes of bupivacaine 0.25% caudal
block on different hemodynamic parameters assessed by electrical cardiometry.
Hypothesis:
We hypothesized that different volumes of plain bupivacaine 0.25% caudal block could have
direct effects on different hemodynamic parameters in pediatrics undergoing lower abdominal
surgeries.
Methods:
The study is a double blinded randomized controlled trial that will be conducted at Abu Al
Reesh Children's Hospital, Faculty of Medicine, Cairo University after approval of research
and ethics committees.
Children will be recruited into the trial during pre-operative assessment. Recruited children
will be randomly assigned to one of three groups in a 1:1:1 ratio; (Group 0.8-G) to receive
general anesthesia and caudal block with 0.8 ml/kg of bupivacaine 0.25% and (Group 1.2-G) to
receive general anesthesia and caudal block with 1.2 ml/kg of bupivacaine 0.25% and (Group G)
to receive general anesthesia with local infiltration of the wound or transversus abdominis
plan block (TAPB) at the end of the procedure.
Randomization will be achieved using a computer-generated sequence. Concealment will be
achieved using opaque envelopes.
All children will be anesthetized in accordance with the local policy of pediatric anesthesia
unit in Abu El-Reesh pediatric hospital-Cairo university.
After preoperative examination and upon arrival to the operating room heart rate HR,
noninvasive blood pressure NBP and oxygen saturation SPO2 will be monitored using standard
monitor (drȁger infinity vista XL) before inhalational induction of anesthesia using
titration of sevoflurane in oxygen air mixture 60% (starting from 3% up to 8%) until the
child is put to sleep. Electrical cardiometry device (ICON; Cardiotonic, Osypka; Berlin,
Germany) will be applied to the patient through 4 ECG electrodes at the following sites:
(forehead, left side of the neck, left mid-axillary line at the level of xiphoid process and
left thigh). Patient's sex, height, and weight will be entered into the device, which is set
to estimate cardiovascular parameters at a 20-beat moving average recorded every10 seconds.
The ECG electrodes will be placed before induction for cooperative children. Baseline
electrical cardiometry (ICON) data (Cardiac output, Cardiac index, Stroke volume, Stroke
volume variation, Stroke index, Systemic vascular resistance, Systemic vascular resistance
index, ICON, VIC, Thoracic fluid index, Left cardiac work, Systolic time ratio, Pre ejection
period, Left ventricular ejection time) will be recorded by averaging 3 sets of data over 30
seconds by an anesthesia resident who is blinded to the children groups.
After securing an intravenous line anesthesia will be completed with 1-2µg/kg of fentanyl and
atracurium 0.5 mg/kg to facilitate endotracheal intubation. Anesthesia will be maintained by
using 1-1.5% isoflurane in a mixture of oxygen and air (50/50) and atracurium top ups at a
dose of 0.1mg/kg every 30 minutes.
The concealed envelopes will then be opened by a second anesthesia resident (who will not be
involved in patient management) and he will be responsible for preparing and giving the
caudal block for the caudal groups as instructed in the envelope.
Children in groups (0.8-G) and (1.2-G) will then be positioned on their right side, and a
22-gauge needle will be aseptically inserted into the caudal epidural space. Bupivacaine
0.25% at a dose of 0.8 ml/kg and 1.2 ml/kg making sure not to exceed a maximum of 2.5 mg/kg
will be slowly injected. After repositioning the children on their backs, a 10-min
steady-state period without surgical stimulation will be permitted during which a multiple
set of measurements will be obtained every 2 minutes (a single set of measurements will be
recorded by averaging 3 sets of data over 30 seconds), and surgery will be started after this
period. Caudal success will be defined as change of hemodynamics (heart rate and or blood
pressure) < 20% of base line parameters to surgical incision without need for additional
analgesics or increase of inhalational anesthetics. Patients with caudal failure will be
excluded from the study.
In group G the surgery will be started after 10 minutes from the induction of anesthesia
where a multiple sets of ICON measurements will be obtained every 2 minutes (a single set of
measurements will be recorded by averaging 3 sets of data over 30 seconds), from the previous
baseline measurements.
In all groups ICON measurements will be obtained every 10 minutes after start of surgery till
the end of surgery.
In all groups HR, NBP, SPO2 and end tidal CO2 will be measured every 2 minutes for 10 minutes
after induction of anesthesia then every 10 minutes till the end of surgery.
All children will receive a loading dose of 10 ml/kg of lactated ringer solution over 10
minutes after induction of anesthesia and will be maintained on 3 ml/kg/h lactated ringer
solution.